Zhong Lun Research
-
-
-
China's CSL Amendment: Six Highlights and Compliance Guidance
The CSL Amendment introduces a more formidable penalty regime while concurrently offering compliance incentives.
2025-12-08
-
-
-
-
Regulatory Compliance: A New Era for China's Biotech Innovation
The Regulation sets unified rules for clinical studies and translational applications of new biomedical technologies.
2025-12-01
-
Zhong Lun Deals
-
- Zhong Lun Advises Nexus Point on Its Strategic Investment in Peley Corporation
-
Zhong Lun Advises Nexus Point on Its Strategic Investment in Peley Corporation
-
- Zhong Lun Represented the Management Team of Yoplait in the Disposal of Yoplait China
-
Zhong Lun Represented the Management Team of Yoplait in the Disposal of Yoplait China
-
- Zhong Lun Represents Adicon to Acquire Crown Biosciences
-
Zhong Lun Represents Adicon to Acquire Crown Biosciences
-
Zhong Lun Honors
Zhong Lun Garners 153 Honors across 40 Practice Areas in Chambers Greater China Region Guide 2025
-
- 2320 + Professionals
-
- 390 + Partners
-
- 24 Practices
-
- 19 Industries
-
- 18 Offices